Natera, Inc. ($NTRA) Stock Forecast: Up 16.5% Today

What is Natera, Inc.?

Natera (NTRA) is a leading biotechnology company specializing in genetic testing and analysis. The company is known for its innovative solutions in the field of personalized medicine.

Why is Natera, Inc. going up?

NTRA stock is up 16.5% on Aug 8, 2025 13:42

• Natera (NTRA) reported a Q2 loss but surpassed revenue estimates, indicating strong top-line growth.
• The positive revenue surprise likely boosted investor confidence in the company's long-term growth prospects.
• Investors may be optimistic about Natera's future potential in the genetic testing market, driving the bullish movement in the stock.
• The market may be interpreting the revenue beat as a sign of Natera's ability to capitalize on the growing demand for personalized healthcare solutions, leading to the bullish momentum in the stock.

NTRA Price Chart

NTRA Technical Analysis

NTRA News

Natera ( NTRA ) Reports Q2 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -23.33% and +15.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2680777/natera-ntra-reports-q2-loss-tops-revenue-estimates

Trending Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

Dogecoin ($DOGE) Crypto Forecast: Up 6.7% Today

Doximity, Inc. ($DOCS) Stock Forecast: Up 12.4% Today

The Trade Desk Inc ($TTD) Stock Forecast: Down 38.0% Today

Natera, Inc. Price History

08.07.2025 - NTRA Stock was up 16.5%

• Natera (NTRA) reported a Q2 loss but surpassed revenue estimates, indicating strong top-line growth.
• The positive revenue surprise likely boosted investor confidence in the company's long-term growth prospects.
• Investors may be optimistic about Natera's future potential in the genetic testing market, driving the bullish movement in the stock.
• The market may be interpreting the revenue beat as a sign of Natera's ability to capitalize on the growing demand for personalized healthcare solutions, leading to the bullish momentum in the stock.

13.10.2024 - NTRA Stock was up 15.7%

• Natera (NTRA) reported a Q3 loss but exceeded revenue estimates, which may have positively influenced investor sentiment.
• The bullish position taken by investors in the options market indicates confidence in Natera's future performance.
• The combination of beating revenue estimates and positive investor sentiment from the options market likely contributed to the strong bullish movement in Natera's stock today.

09.06.2025 - NTRA Stock was up 5.1%

• There was a strong bullish movement in Natera Inc. today.
• The rise in revenues and profits of a competitor in the AI tools and data services sector may have positively influenced market sentiment towards Natera Inc.
• Investors show optimism about Natera Inc.'s potential for revenue growth and improved margins, similar to the success seen by its competitor.
• The increasing adoption of AI technologies in the healthcare and biotechnology industries could be driving positive investor sentiment towards companies like Natera Inc.

13.10.2024 - NTRA Stock was up 17.2%

• Natera (NTRA) stock experienced a strong bullish movement following the release of its third-quarter financial results.
• Analysts increased their forecasts for Natera after the company reported a quarterly loss that was lower than expected and topped revenue estimates.
• The options market also indicated a bullish sentiment towards Natera, with significant funds taking a positive position in the company.
• The positive performance of Natera stock could be attributed to the company's strong financial results and optimistic revenue guidance for the future, leading to increased investor confidence and driving the stock price higher.

25.01.2025 - NTRA Stock was down 5.1%

• Natera (NTRA) showed significant bearish movement today.
• Comparison with Gilead Sciences (GILD) in the medical stocks sector may have revealed Natera's underperformance, influencing a negative market sentiment.
• Investors are expressing concerns about Natera's competitive position in the sector, potentially impacting its stock price adversely.
• It is likely that Natera encountered specific challenges or setbacks, prompting investors to sell shares and leading to the bearish movement.

18.11.2024 - NTRA Stock was down 5.3%

• Despite the "Golden Cross" signal indicating a bullish trend, Natera (NTRA) has faced bearish movement recently.
• While surpassing the resistance at the 20-day simple moving average could signal short-term bullish momentum, today's bearish movement suggests other influencing factors.
• Factors such as broader market conditions, company-specific news, or profit-taking activities may be contributing to the downward pressure on Natera's stock price.
• Traders should consider technical signals and external factors when deciding on transactions involving Natera (NTRA) in the current market climate.

07.07.2024 - NTRA Stock was up 6.3%

• Natera has outperformed the market significantly over the past 5 years, showcasing strong growth prospects and investor confidence.
• The company's participation in the Canaccord Genuity 44th Annual Growth Conference likely generated positive investor sentiment and highlighted Natera's strategic initiatives and future growth prospects.
• The live webcast of the event provided investors with an opportunity to gain insights into Natera's advancements in cell-free DNA testing, potentially driving further interest and investment in the company.

09.07.2024 - NTRA Stock was up 6.8%

• Natera reported a Q2 loss but surpassed revenue estimates, indicating strong performance and potential growth prospects.
• The stock has outperformed the market over the past 5 years, showcasing consistent growth and investor confidence.
• Participation in the Canaccord Genuity 44th Annual Growth Conference suggests Natera's commitment to showcasing its strategies and growth prospects, which might have positively influenced investor sentiment.
• Overall, the combination of positive financial results, long-term market outperformance, and active participation in industry events likely contributed to the bullish movement in Natera's stock today.

20.01.2025 - NTRA Stock was down 5.3%

• Over the past 5 years, Natera has outperformed the market significantly with an average annual return of 36.12%.
• Despite breaking above the 20-day moving average recently, suggesting a positive momentum, the stock saw a bearish movement today.
• The bearish movement may be due to profit-taking by investors or broader market factors affecting the stock negatively.
• Investors should monitor any upcoming developments related to Natera to determine if the bearish trend is a temporary correction or a more sustained shift in market sentiment.

11.01.2025 - NTRA Stock was down 3.4%

• Strong performance by Natera in the past 5 years may have prompted profit-taking by investors, resulting in a decline in the stock.
• Investors who had gained significantly from Natera's stock in the past might have opted to divest, contributing to the downward trend in the stock price.
• The market sentiment appears to have turned bearish possibly due to perceived overvaluation following the impressive performance, leading to a sell-off and the observed decline in stock price today.

23.03.2025 - NTRA Stock was up 5.1%

• Demonstrating a remarkable performance over the last five years, surpassing the market by 19.34% annually, has attracted investors interested in high returns.
• With a focus on genetic testing and a market capitalization of $20.02 billion, Natera holds a prominent position within the biotech sector, instilling confidence in investors.
• The upward trend in NTRA's stock performance today may be linked to the ongoing positive outlook regarding the company's growth potential and market outperformance.

28.01.2025 - NTRA Stock was down 5.5%

• The bearish movement in NTRA today could be attributed to the reported Q4 loss, despite topping revenue estimates.
• Investors may have reacted negatively to the earnings surprise and uncertainties about the company's future profitability.
• The market sentiment might have shifted due to concerns raised by the financial performance, leading to a sell-off of Natera shares.
• The slight miss in earnings and revenue could have caused investors to reassess the stock's valuation and potential growth prospects, resulting in the bearish movement observed today.